Beneficial brain autoimmunity?
Wekerle
Hartmut
H
Max Planck Institute for Neurobiologie, Martinsried, Germany. hwekerle@neuro.mpg.de
Hohlfeld
Reinhard
R
D000074323:Alemtuzumab; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000627:therapeutic use; D015551:Autoimmunity / Q000502:physiology*; D001921:Brain / Q000276:immunology* / Q000378:metabolism; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D051379:Mice; D009103:Multiple Sclerosis / Q000276:immunology / Q000378:metabolism / Q000628:therapy; D009474:Neurons / Q000276:immunology / Q000378:metabolism
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D007155:Immunologic Factors; D000074323:Alemtuzumab